|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Histamine ELISA | C-Peptide ELISA Assay | Epstein-Barr Virus (EBNA-1) IgM ELISA | Thioredoxin ELISA Assay | Vitamin D (25OH) Total ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB89128R | IB79101 | IB79860 | 27417 | KAP1971 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme Immunoassay for the determination of Histamine in plasma and urine. In combination with the supplementary kit (IB89145), the assay is performed for the histamine release in heparinized whole blood. For research use only, not for use in diagnostic procedures. | Solid phase enzyme immunoassay (ELISA) for the determination of C-Peptide in serum, plasma and urine. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay for the determination of IgM-class antibodies to Epstein-Barr virus nuclear-1 antigen (EBV-EBNA-1) in human serum or plasma. For research use only - not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Thioredoxin in serum, EDTA plasma, urine and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Immunoenzymetric assay (ELISA) for the quantitative determination of 25-hydroxyvitamin D2 and D3 (25OH-D2 and 25OH-D3) in serum and plasma. 510(k) cleared. |
| Detection Target | Histamine | Dopamine | Schistosoma mansoni IgG | Anti-Certolizumab pegol (Cimzia®) | Vitamin D (25OH) Total |
| Sample Type | Plasma and urine. Whole blood may be used with supplementary Histamine (Release) kit, catalog # IB89145. Please see protocol for more information. | Tissue Homogenates, Dialysates, Urine | Serum, Blood Plasma | Serum and plasma. | Serum, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 0.5 - 50 ng/mL | 0.2 to 16.0 ng/mL | A cut-off control is used for the interpretation of results. | 3.91 to 250 ng/mL | 0 / 3.44 - 122.760 ng/mL |
| Sensitivity | Plasma: 0.12 ng/mL; Urine: 0.30 ng/mL. | 0.25 ng/mL x C (must be multipled by a correction factor dependent on sample volume). | 93.75% (95% confidence interval: 82.8% - 98.69%) | 40 ng/mL | 3.35 ng/mL |
| Assay Time | 45 min. incubation (RT) + 15 min. (RT) + 3 hours (RT) + 30 min. (RT) + 30 min. (RT) = 5 hours total incubation time. | 1 hr 50 mins (incubation) | 1 hr 45 mins (incubation) | 2 hrs (incubation) | 2 hrs, 45 minutes (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |